Popović, M., Dedić Plavetić, N., Vrbanec, D., Marušić, Z., Mijatović, D. & Kulić, A. (2023). Interleukin 17 in early invasive breast cancer. Frontiers in Oncology, 13.. doi: 10.3389/fonc.2023.1171254
Popović, Marina, et al. "Interleukin 17 in early invasive breast cancer." Frontiers in Oncology, vol. 13, 2023. https://doi.org/10.3389/fonc.2023.1171254
Popović, Marina, Natalija Dedić Plavetić, Damir Vrbanec, Zlatko Marušić, Davor Mijatović and Ana Kulić. "Interleukin 17 in early invasive breast cancer." Frontiers in Oncology 13 (2023). https://doi.org/10.3389/fonc.2023.1171254
Popović, M., et al. (2023) 'Interleukin 17 in early invasive breast cancer', Frontiers in Oncology, 13. doi: 10.3389/fonc.2023.1171254
Popović M, Dedić Plavetić N, Vrbanec D, Marušić Z, Mijatović D, Kulić A. Interleukin 17 in early invasive breast cancer. Frontiers in Oncology [Internet]. 2023 June 23 [cited 2024 October 04];13. doi: 10.3389/fonc.2023.1171254
M. Popović, N. Dedić Plavetić, D. Vrbanec, Z. Marušić, D. Mijatović and A. Kulić, "Interleukin 17 in early invasive breast cancer", Frontiers in Oncology, vol. 13, June 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:252900. [Accessed: 04 October 2024]